$CAPR inspire trial primary outcome #1 is to showcase the safety of CAP-1002. The main reason for FDA not giving CAP-1002 Accelerated Approval is they want more people to undergo the treatment to verify it is safe. This is the real reason for the trial. They thought they could get AA on data alone and end of summer realized the needed to show more data around safety. We will get AA in Q1 of 2021. Mark it and take it to the bank! MC will be $5B+ with AA.
  • 7